(VIANEWS) - Shares of FAGRON (BEL 20: FAGR.BR) jumped by a staggering 15.33% in 5 sessions from 13.18 € to 15.20 € at 01:13 EST on Monday, following the last session's upward trend. BEL 20 is falling 0.88% to 3,887.49 €, after two sequential sessions in a row of gains.
About FAGRON
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Earnings Per Share
As for profitability, FAGRON has a trailing twelve months EPS of 0.82 €.
PE Ratio
FAGRON has a trailing twelve months price to earnings ratio of 18.54. Meaning, the purchaser of the share is investing 18.54 € for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FAGRON's stock is considered to be overbought (>=80).
More news about FAGRON (FAGR.BR).